Literature DB >> 2705635

Can patients with chest pain and normal coronary arteries be discriminated from those with coronary artery disease prior to coronary angiography?

V Mukerji1, M A Alpert, J E Hewett, B M Parker.   

Abstract

To determine whether the precatheterization clinical data in patients with chest pain could be used to discriminate patients with normal coronary arteries (NCA) from those with coronary artery disease, the authors compared 125 consecutive patients with less than 30% stenosis of all major coronary arteries and 125 patients with greater than 60% stenosis of one or more major coronary arteries. Clinical characteristics that occurred more frequently in patients with NCA were: nonexertional pain, pain to the left of the sternum, sharp pain, associated palpitations, absence of typical relief with sublingual nitroglycerin, pain commencing less than one week or more than ten years prior to coronary angiography, a normal electrocardiogram, and negative results from a treadmill stress test or from thallium scintigraphy. However, none of these clinical features, either singly or in combination, could be used to identify the patients with NCA with certainty.

Entities:  

Mesh:

Year:  1989        PMID: 2705635

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  3 in total

Review 1.  Chest pain and angiographically normal coronary arteries. Implications for treatment.

Authors:  V Mukerji; B D Beitman; M A Alpert
Journal:  Tex Heart Inst J       Date:  1993

Review 2.  North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management angina. North of England Stable Angina Guideline Development Group.

Authors: 
Journal:  BMJ       Date:  1996-03-30

3.  Chest pain in primary care: is the localization of pain diagnostically helpful in the critical evaluation of patients?--A cross sectional study.

Authors:  Stefan Bösner; Katharina Bönisch; Jörg Haasenritter; Patrice Schlegel; Eyke Hüllermeier; Norbert Donner-Banzhoff
Journal:  BMC Fam Pract       Date:  2013-10-18       Impact factor: 2.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.